SanofiSNYNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 39,175 | 40,561 | 41,618 |
| Gross Profit | 26,920 | 28,679 | 28,990 |
| Operating Income | 8,126 | 10,162 | 6,960 |
| Net Income | 6,223 | 8,371 | 5,400 |
| EBITDA | 11,538 | 13,510 | 11,390 |
| EPS Diluted | 2.49 | 3.18 | 2.15 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 10,098 | 12,736 | 8,710 |
| Total Current Assets | 30,564 | 34,026 | 30,655 |
| Total Assets | 120,242 | 126,722 | 126,464 |
| Total Current Liabilities | 21,295 | 23,964 | 24,194 |
| Total Liabilities | 51,211 | 51,570 | 52,111 |
| Total Equity | 68,681 | 74,784 | 74,040 |
| Total Debt | 22,414 | 21,212 | 18,697 |
| Net Debt | 12,316 | 8,476 | 9,987 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 10,522 | 10,526 | 10,258 |
| Capital Expenditure | -2,043 | -2,201 | -1,619 |
| Free Cash Flow | 8,479 | 8,325 | 8,639 |
| Stock-Based Comp | 244 | 245 | 0 |
| Net Change in Cash | -3,817 | 2,638 | -4,026 |